| P50 | author | Derek M. Yellon | Q33528795 |
| | Xavier Rossello | Q56561461 |
| | Sean M. Davidson | Q56988847 |
| | Jaime A Riquelme | Q57560160 |
| | Bart Vanhaesebroeck | Q64481959 |
| P2093 | author name string | Zhenhe He | |
| | Stasa Taferner | |
| P2860 | cites work | Cardiac regulation by phosphoinositide 3-kinases and PTEN | Q24317248 |
| | A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling | Q24599676 |
| | Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning | Q28080777 |
| | Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 |
| | Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation | Q28594707 |
| | Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 |
| | The mitochondrial permeability transition pore and its role in cell death | Q29614183 |
| | Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection | Q33226934 |
| | Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial | Q34204296 |
| | Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. | Q50512636 |
| | PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heart. | Q51308924 |
| | Hypoxic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway. | Q54353573 |
| | PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. | Q54686097 |
| | Preconditioning the human myocardium | Q72225812 |
| | Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart | Q78052924 |
| | Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report | Q79421557 |
| | ??? | Q27703515 |
| | Remote ischemic conditioning. | Q34458416 |
| | Myocardial reperfusion injury. | Q34687124 |
| | Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? | Q35286339 |
| | Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy | Q35578778 |
| | Signalling by PI3K isoforms: insights from gene-targeted mice. | Q36092041 |
| | Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy | Q36350066 |
| | Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer | Q36557786 |
| | The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. | Q36751486 |
| | Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. | Q36836773 |
| | Preconditioning and postconditioning: united at reperfusion. | Q36903277 |
| | Temporally controlled overexpression of cardiac-specific PI3Kalpha induces enhanced myocardial contractility--a new transgenic model | Q36995156 |
| | Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development | Q37223903 |
| | Preconditioning the diabetic human myocardium | Q37311040 |
| | Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation | Q37316471 |
| | Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model | Q37321912 |
| | Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction | Q37324188 |
| | Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis | Q37360125 |
| | Specific PI3K isoform modulation in heart failure: lessons from transgenic mice | Q37868990 |
| | STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication | Q38480556 |
| | Molecules in medicine mini-review: isoforms of PI3K in biology and disease | Q38666875 |
| | Critical Issues for the Translation of Cardioprotection | Q38690057 |
| | Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning | Q38931520 |
| | Cardioprotection: The Disconnect Between Bench and Bedside. | Q38934508 |
| | lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. | Q39048983 |
| | Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors | Q39735943 |
| | Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling | Q43819715 |
| | Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. | Q44328589 |
| | G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning | Q44805541 |
| | Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning | Q44974883 |
| | Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial | Q45238837 |
| | Ischemic postconditioning in pigs: no causal role for RISK activation. | Q46225223 |
| | Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning | Q46440002 |
| | Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways | Q46717185 |
| | Insulin Postconditioning Reduces Infarct Size in the Porcine Heart in a Dose-Dependent Manner | Q47291028 |
| | Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia-Reperfusion Injury: Impact of Ischemia and Reperfusion Length on Infarct Size and LDH Release | Q47363519 |
| | Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion | Q47379862 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P304 | page(s) | 66 | |
| P577 | publication date | 2017-10-17 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | The role of PI3Kα isoform in cardioprotection | |
| P478 | volume | 112 | |